NeuroSense Announces The Peer-Reviewed Publication Of PrimeC Phase IIa ALS Study In Amyotrophic Lateral Sclerosis And Frontotemporal Degeneration
CAMBRIDGE, Mass., Sept. 19, 2022 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today announced the
NeuroSense Therapeutics Shares Move Sharply Higher; Traders Circulate Presentation Slide Saying PrimeC ‘Significantly Alters Key ALS Biomarkers’
https://docs.publicnow.com/viewDoc?hash_primary=E643C899EAD84D83637D61C470FEB3BAE9F37120
Coinbase, Moderna And 56 Biggest Movers From Yesterday
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.
Why Is DoorDash Down By 8%? 38 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.
Why Is SCWorx Jumping By Around 36%? 20 Stocks Moving In Wednesday’s Pre-Market Session
Gainers
Hexo Corp (NYSE: HEXO) rose 106.8% to $0.43 in pre-market trading. HEXO’s shareholders, on Tuesday, approved the note transaction with Tilray Brands.
Akerna Shares Dip 53%, Here’s 78 Biggest Movers From Yesterday
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.